The global heparin market is poised for steady growth, valued at USD 7.77 billion in 2024 and projected to rise from USD 7.96 billion in 2025 to reach USD 9.62 billion by 2033, registering a CAGR of 2.4% during the forecast period. Heparin, a vital anticoagulant drug, plays a critical role in preventing and treating blood clots, making it indispensable in conditions like deep vein thrombosis...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek
Bangla